PD 174265 is a potent, selective, and reversible epidermal growth factor receptor (EGFR) inhibitor with an IC50 of 0.45 nM. It is a valuable research tool for studying EGFR-driven signaling pathways in cancer research, applicable in both in vitro enzymatic assays and cellular studies.
Molekulargewicht:
371.23
Reinheit:
99.51% (May vary between batches)
CAS Nummer:
[216163-53-0]
Formel:
C17H15BrN4O
Target-Kategorie:
EGFR
Anwendungsbeschreibung:
Solubility: DMSO:10 mg/mL (26.94 mM)
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten